Sirona Biochem Announces Successful Development of a Third Skin Lightener with Superior Safety and Efficacy
Sirona Biochem: Positive Preclinical Toxicology Results for its SGLT2 Inhibitor Trigger Milestone Payment from Wanbang Biopharmaceuticals
Sirona Biochem Appoints Dr. Martin Gleave to its Board of Directors
Sirona Biochem to Present New Results at BIO Europe 2015
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 60
- Next Page »